company background image
8432

TSH Biopharm TPEX:8432 Stock Report

Last Price

NT$43.25

Market Cap

NT$1.7b

7D

-5.0%

1Y

8.9%

Updated

04 Oct, 2022

Data

Company Financials
8432 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends1/6

8432 Stock Overview

TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan.

TSH Biopharm Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TSH Biopharm
Historical stock prices
Current Share PriceNT$43.25
52 Week HighNT$51.90
52 Week LowNT$39.00
Beta-0.076
1 Month Change-8.47%
3 Month Change10.47%
1 Year Change8.94%
3 Year Change-46.01%
5 Year Change-41.24%
Change since IPO-25.32%

Recent News & Updates

Shareholder Returns

8432TW PharmaceuticalsTW Market
7D-5.0%-2.2%-3.5%
1Y8.9%19.5%-18.3%

Return vs Industry: 8432 underperformed the TW Pharmaceuticals industry which returned 19.5% over the past year.

Return vs Market: 8432 exceeded the TW Market which returned -18.3% over the past year.

Price Volatility

Is 8432's price volatile compared to industry and market?
8432 volatility
8432 Average Weekly Movement6.1%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement5.1%
10% most volatile stocks in TW Market8.2%
10% least volatile stocks in TW Market2.4%

Stable Share Price: 8432 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: 8432's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a80Sze-Yuan Yanghttps://www.tshbiopharm.com

TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan.

TSH Biopharm Corporation Limited Fundamentals Summary

How do TSH Biopharm's earnings and revenue compare to its market cap?
8432 fundamental statistics
Market CapNT$1.66b
Earnings (TTM)NT$60.08m
Revenue (TTM)NT$436.51m

27.6x

P/E Ratio

3.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
8432 income statement (TTM)
RevenueNT$436.51m
Cost of RevenueNT$177.40m
Gross ProfitNT$259.11m
Other ExpensesNT$199.03m
EarningsNT$60.08m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)1.56
Gross Margin59.36%
Net Profit Margin13.76%
Debt/Equity Ratio0%

How did 8432 perform over the long term?

See historical performance and comparison

Dividends

3.5%

Current Dividend Yield

96%

Payout Ratio